Riskpilot← Back to searchSign inGet full accessSTRAGEN NORDIC A/S
A/SActiveCVR 26717825Industrivej 24FWholesale of pharmaceutical and medical goods · NACE 4646Est. 20024 employees
Revenue 2024
DKK 8,5M
+43% vs 2023
EBITDA margin
38.0%
+623% vs 2023
Equity ratio
55.8%
Financial strength
Net profit 2024
DKK 2,7M
+676% vs 2023
| Revenue | DKK 8,5M | +43% |
| EBITDA | DKK 3,2M | +623% |
| Net profit | DKK 2,7M | +676% |
| Total assets | DKK 16M | -40% |
| Equity | DKK 8,9M | +43% |
| Employees | 4 | — |
Legal name
STRAGEN NORDIC A/S
CVR number
26717825
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
25. juli 2002
Share capital
DKK 501.000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør alene eller af den samlede bestyrelse.
Company purpose
Selskabets formål er distribution af farmaceutiske produkter i de Nordiske Lande samt Estland, Letland og Lithauen.
Address
Industrivej 24F
Phone
+4548108810
Email
info@stragen.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 6.764 | 4.331 | 17.271 | 5.931 | 8.494 |
| Staff expenses | -3.742 | -3.686 | -3.906 | -3.610 | -2.056 |
| EBITDA | 3.022 | 645 | -2.863 | -616 | 3.226 |
| Depreciation & amort. | -7 | -0 | -0 | -0 | -0 |
| EBIT | 3.015 | 645 | -2.863 | -616 | 3.226 |
| Net financials | 327 | -322 | -394 | 153 | -561 |
| Profit before tax | 3.342 | 323 | -3.257 | -463 | 2.665 |
| Tax | 740 | 68 | -0 | -0 | -0 |
| Net profit | 2.602 | 255 | -3.257 | -463 | 2.665 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 22.965 | 24.225 | 31.543 | 26.702 | 15.981 |
| Equity | 9.712 | 9.967 | 6.709 | 6.246 | 8.912 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 13.253 | 14.258 | 24.833 | 20.455 | 7.069 |
| Total debt | 13.253 | 14.258 | 24.833 | 20.455 | 7.069 |
EBITDA margin
38.0%
This company
15.8%
Market median
+141% vs market
20202024
Equity ratio
55.8%
This company
38.2%
Market median
+46% vs market
20202024
Return on equity
29.9%
This company
18.4%
Market median
+63% vs market
20202024
Net profit margin
31.4%
This company
8.1%
Market median
+288% vs market
20202024
Asset turnover
0.53×
This company
1.12×
Market median
-53% vs market
20202024
Debt / equity
0.79×
This company
0.62×
Market median
+27% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
AF Chief Executive Officer | Chief Executive Officer | 2025 |
SI Founder | Founder | 2002 |
| Former (6) | ||
AT Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
AS Chief Executive Officer | Chief Executive Officer | 2003 – 2010 |
LJ Chief Executive Officer | Chief Executive Officer | 2010 – 2017 |
JT Chief Executive Officer | Chief Executive Officer | 2017 – 2021 |
LP Chief Executive Officer | Chief Executive Officer | 2017 – 2017 |
ML Management | Management | 2002 – 2003 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2025 | |
| Board of Directors | 2025 | |
| Chairman | 2025 | |
| Former (12) | ||
| Board of Directors | 2021 – 2021 | |
| Board of Directors | 2010 – 2020 | |
| Chairman | 2021 – 2022 | |
| Board of Directors | 2002 – 2003 | |
| Chairman | 2014 – 2021 | |
| Board of Directors | 2020 – 2021 | |
| Chairman | 2002 – 2013 | |
| Board of Directors | 2002 – 2006 | |
| Board of Directors | 2013 – 2014 | |
| Board of Directors | 2021 – 2022 | |
| Chairman | 2022 – 2023 | |
| Board of Directors | 2022 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2023 | |
| Individual | 100% | 100% | 2002 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of STRAGEN NORDIC A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anne Franch Nyquist-Hansen | Chief Executive Officer | 0 companies |
| STRAGEN INVESTMENT B.V | Founder | 0 companies |
| Antoine Tétard | Chief Executive Officer | 0 companies |
| Anni Søgaard | Chief Executive Officer | 0 companies |
| Laurent Jean Forestier | Chief Executive Officer | 0 companies |
| Jan Tétard | Chief Executive Officer | 0 companies |
| Laurent Pinchard | Chief Executive Officer | 0 companies |
| Morten Lodberg Petersen | Management | 0 companies |
| Arnaud Etienne | Board of Directors | 0 companies |
| Antoine Tétard | Board of Directors | 0 companies |
| Amine Achite-Henni | Chairman | 0 companies |
| Tom Carlos Buhmann | Board of Directors | 0 companies |
| Jean-Luc Tetard | Chairman | 0 companies |
| Jean-Baptiste Pierre Marie Amadieu | Board of Directors | 0 companies |
| Jean-Luc Tetard | Chairman | 0 companies |
| Jean-Yves Paul Etienne Desmottes | Board of Directors | 0 companies |
| Niels Jørgen Kornerup | Board of Directors | 0 companies |
| Yves Josef Gaby Decadt | Board of Directors | 0 companies |
| Ludovic Alonzi | Board of Directors | 0 companies |
| Michele Mencarelli | Board of Directors | 0 companies |
| Frank Bouisset | Chairman | 0 companies |
| Nicholas Stopford | Board of Directors | 0 companies |
| Didier Remi Dargent | Chairman | 0 companies |